Lung inflammation and interstitial fibrosis by targeted alveolar epithelial type I cell death

Front Immunol. 2023 Sep 28:14:1261483. doi: 10.3389/fimmu.2023.1261483. eCollection 2023.

Abstract

Introduction: The pathogenesis of chronic lung diseases is multifaceted with a major role of recurrent micro-injuries of the epithelium. While several reports clearly indicated a prominent role for surfactant-producing alveolar epithelial type 2 (AT2) cells, the contribution of gas exchange-permissive alveolar epithelial type 1 (AT1) cells has not been addressed yet. Here, we investigated whether repeated injury of AT1 cells leads to inflammation and interstitial fibrosis.

Methods: We chose an inducible model of AT1 cell depletion following local diphtheria toxin (DT) administration using an iDTR flox/flox (idTRfl/fl) X Aquaporin 5CRE (Aqp5CRE) transgenic mouse strain.

Results: We investigated repeated doses and intervals of DT to induce cell death of AT1 cells causing inflammation and interstitial fibrosis. We found that repeated DT administrations at 1ng in iDTRfl/fl X Aqp5CRE mice cause AT1 cell death leading to inflammation, increased tissue repair markers and interstitial pulmonary fibrosis.

Discussion: Together, we demonstrate that depletion of AT1 cells using repeated injury represents a novel approach to investigate chronic lung inflammatory diseases and to identify new therapeutic targets.

Keywords: AT1 cell depletion; cell death; iDTR; lung injury; sterile inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Death
  • Fibrosis
  • Inflammation
  • Mice
  • Mice, Transgenic
  • Pneumonia*
  • Reinjuries*

Grants and funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by CNRS, University of Orleans, ‘Fondation pour la Recherche Médicale’ (FRM EQU202003010405), European funding in Region Centre-Val de Loire (FEDER BIOTARGETII EX005756 and TARGET-Ex N° EX016008).